Status:
COMPLETED
A Validation Study for Detecting Chlamydia and Gonorrhea in Rectal Samples
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Gonorrhea
Chlamydia
Eligibility:
All Genders
18+ years
Brief Summary
Our hypothesis is that nucleic acid amplification testing (NAAT) with the APTIMA Combo2 (AC2) will have greater sensitivity than culture in detecting Neisseria gonorrhoeae in rectal samples. We also h...
Detailed Description
This research is being done to compare the results of tests for diagnosing sexually transmitted infections (STI) from rectal samples. Specifically, this study will test for gonorrhea and Chlamydia fro...
Eligibility Criteria
Inclusion
- Male and female subjects aged 18 and older
- Women or men who have a history of engaging in receptive anal intercourse
- Willing to provide written informed consent for participation in this study
Exclusion
- Use of oral antibiotics in the past 7 days
- Use of rectal douche or other rectal product in the past 24 hours
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
399 Patients enrolled
Trial Details
Trial ID
NCT00827697
Start Date
May 1 2009
End Date
March 1 2010
Last Update
August 17 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Magee-Womens Hospital of UPMC
Pittsburgh, Pennsylvania, United States, 15213
2
Pittsburgh AIDS Center for Treatment (PACT)
Pittsburgh, Pennsylvania, United States, 15213